Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
From Discovery To Patients: An Integrated Service For ADC Development
Building a safe, effective antibody-drug conjugate is complex. Learn how streamlined design and manufacturing can reduce delays and help promising candidates reach patients faster.
-
How To Achieve Late-Phase Success In Complex OSD Development
Late-phase OSD scale-up demands more than technical know-how. This paper examines the frameworks, tools, and partnership models that determine whether promising molecules reach commercial production reliably.
-
Reducing Uncertainty In Early Oral Drug Development
Five recurring decision points in early oral solid dose development carry outsized downstream consequences. AI/ML-driven predictive modeling is reframing how teams manage those decisions under API and timeline constraints.
-
Lipid Formulation Development: Why Softgels Are The Technology Of Choice
Low bioavailability affects roughly 80% of APIs, yet many drug developers default to standard OSD forms. This paper examines why softgels deserve earlier consideration in formulation strategy.
-
5 Hidden Risks In Early-Phase OSD Formulation Development
Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins
Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.
-
Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity
Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.
-
Differentiate Challenging Site-Specific Isomeric Amino Acids
Learn how high-resolution ion mobility, pre-IMS fragmentation, and product ion analysis can resolve difficult peptide isomers and localize structural differences, supporting confident characterization.
-
Increase Throughput For Intact Mass Confirmation And Impurity Screening
Accelerate intact mass analysis of GLP-1 analogues with automated purity calculations, sub-ppm mass accuracy, and impurity detection for consistent results in under one minute per sample.
-
Integrated QC As A Development Strategy: Reducing Late-Stage Analytical Risk
Learn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, strengthen release testing predictability, and help protect critical clinical manufacturing timelines.
FORMULATION DEVELOPMENT SOLUTIONS
- Lyophilization And Sterile Manufacturing
- Human Proximal Tubule Kidney Bio-Kit
- Guarantee A Successful Expansion With An Organoid Expansion Service
- Contract Research Services For Drug Discovery And Development
- Enhance Dissolution Rate With A Single High Performance Excipient
- Granulated Materials: Easy Handling For Improved Process Efficiency
- The In Vitro Model Redefining Drug Discovery And Development
- Human ADME Studies: Human Metabolism Data For Regulatory Submission
- Empowering Biologics Development With HRMS Services
- Leading The Way In Rapid Quantitation Of Host Cell DNA
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- AST Names Industry Veteran Jon Lenihan As Chief Commercial Officer
- JHS And Altoura Selected For BioTools Innovator VANGUARD Level Up-XR Program
- Syntegon Launches New Pilot Scale Tablet Coater For Small Batches
- Cambrex High Point Completes FDA, PMDA And TGA PreApproval Inspections, Advancing Commercial Manufacturing Capabilities
- CleanSpace Names Pharma Industry Veteran Will Knapp Midwest Sales Director
- METTLER TOLEDO Introduces LightningBuild Program For Four-Week Delivery
- Eurofins CDMO Alphora Expands Kilolab And High Potency Development And Manufacturing Capabilities
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies